Pharmacovigilance and pharmaceutical care of traditional Chinese medicine based on ancient pediatric literature

doi:10.19803/j.1672-8629.2022.06.02

Abstract

Abstract: Objective To provide a basis for medication vigilance and pharmacy services for special pediatric populations by mining pediatric ancient literature for awareness of safe medication use in children. Methods By the methods of philology and based on the early stage of the research of "practice of cognition, application, prevention and rescue of drug toxicity" of pharmacovigilance of Chinese medicine, extract related alert expression of the Tang dynasty Luxin Jing, Song dynasty Key to Therapeutics of Children's Diseases and A New Book of Pediatrics, Yuan dynasty Huo You Xin Shu, Ming dynasty You Ke Fa Hui and Qing dynasty Collection of Words on Pediatrics, You Ke Shi Mi seven representative pediatric monographs. Results The ancient books of pediatrics paid attention to the safety of pediatric medicine, and the understanding of pharmacovigilance was more systematic and comprehensive, and the use of medicine was aimed at calmness and harmony, mostly from the spleen and stomach theory of treatment, from the dosage form, dose, course of treatment, preparation, combination and other aspects to enhanced the efficacy and prevented adverse reactions. Conclusion In the face of the phenomenon of irrational use of drugs in clinical practice, the traditional ancient books of pediatrics provide a basis for modern pediatrics to carry out pharmacovigilance, guide the safe and rational use of drugs in clinical practice, and provide direction for the development of pharmacy services.

Key words: children, ancient literature, pharmacovigilance, special population, pharmaceutical care

CLC Number:

WANG Xiaofang, ZHANG Xiaomeng, ZHANG Bing, LIN Zhijian, WEI Changce. Pharmacovigilance and pharmaceutical care of traditional Chinese medicine based on ancient pediatric literature[J]. Chinese Journal of Pharmacovigilance, 2022, 19(6): 591-594.

References

[1] ICH. ICH E11(R1): Addendum: Clinical Investigation of Medicinal Products in the Pediatric Population[EB/OL].(2017-08-18)[2022-01-06]. https://database.Ich.Org/sites/default/files/E11_R1_Addendum.pdf.
[2] ZHANG M, XIAO HL.FDA requirements for pediatric information in human prescription drug and biological product labeling[J]. Drug Evaluation Research, 2020, 43(7): 1228-1232.
[3] Nation Medical Products Administration. National Adverse Drug Reaction Annual Test Report (2014)[EB/OL].(2015-07-17)[2022-01-06]. https://www.nmpa.gov.cn/xxgk/yjjsh/ypblfytb/20150717150401333.html.
[4] Nation Medical Products Administration. National Adverse Drug Reaction Annual Test Report (2016)[EB/OL].(2017-04-28)[2022-01-06]. https://www.nmpa.gov.cn/directory/web/nmpa/xxgk/fgwj/gzwj/gzwjyp/20170428132601249.html.
[5] Nation Medical Products Administration. National Adverse Drug Reaction Annual Test Report (2017)[EB/OL].(2018-04-10)[2022-01-06]. https://www.nmpa.gov.cn/yaopin/ypggtg/ypqtgg/20180413171401472.html.
[6] WANG M.A case of neonatal respiratory and circulatory failure caused by overdose of Yinzhihuang injection and review of litera-ture[J]. Journal of Pediatric Pharmacy, 2011, 17(3): 63-64.
[7] CHEN YH, KUANG JX.Care of 2 cases of allergic reactions caused by intravenous infu-sion of fishy grass[J]. Contemporary Nurse, 2006(8): 95-96.
[8] LIU CH, WU SZ. Luxin Jing(颅囟经)[M]. Beijing: China Medical Science Press, 2020.
[9] QIAN Y.Key to Therapeutics of Children's Diseases(小儿药证直决)[M]. Beijing: People's Medical Publishing House, 2017.
[10] LIU F.A New Book of Pediatrics(幼幼新书)[M]. Beijing: China Medical Science Press, 2017.
[11] ZENG SR.Huo You Xin Shu(活幼心书)[M]. Beijing: People's Medical Publishing House, 2006.
[12] WANG Q.You Ke Fa Hui(幼科发挥)[M]. Beijing: People's Medical Publishing House, 2006.
[13] CHEN FZ.Collection of Words on Pediatrics.(幼幼集成)[M]. Beijing: People's Medical Publishing House, 2006.
[14] SHEN JA.You Ke Shi Mi(幼科释迷)[M]. Beijing: People's Military Medical Publishing House, 2012.
[15] ZHANG B, LIN ZJ, ZHANG XM.Pharmacovigilance of Chinese medi-cine: practice of cognition, application, prevention and rescue of drug toxicity[J]. China Journal of Chinese Materia Medica, 2017, 42(10): 2017-2020.
[16] WANG S, HUANG SZ, CHEN SH.Retrospective analysis of 308 cases of pediatric adverse drug reactions[J]. Journal of Pediatric Pharmacy, 2021, 27(1): 49-52.
[17] ZHAO XH, HAN ZH, LIU H.Outpatient oral chinese patent medicine prescriptions in a grade Ⅲ Level A hospital in 2017[J]. Journal of Pediatric Pharmacy, 2019, 25(3): 47-49.
[18] SHEN YX, LIU ZG, LI SW, et al.Investigation of off-label drug use in pediatric outpatient department of our hospital in 2017[J]. Journal of Pediatric Pharmacy, 2020, 26(3): 31-36.
[19] ZHANG HL, LI L, ZHAO L, et al.Application status of chinese patent medicine in pediatric emergency of our hospital[J]. Journal of Pediatric Pharmacy, 2021, 27(12): 43-46.
[20] HOU JH, WU MY.Exploration of the idea of "maintenance" for children in You Ke Shi Mi[J]. Chinese Medicine Bulletin, 2016, 15(1): 33-35.
[21] ZHANG EJ, MENG JH.Thought pattern of properly counseling medication and safely taking drugs during lactation[J]. Herald of Medicine, 2019, 38(10): 1354-1359.
[22] WU LL.Adverse drug reactions monitoring and rational drug use intervention in pediatrics[J]. Chinese Community Doctors, 2019, 35(8): 85-86.